MATN3 (Center), 220-248 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-MATN3 (Center), 220-248 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityMATN3 (Center), 220-248
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatpeptide affinity purified
Size0.08 mL, 0.4 mL
Concentrationvial concentration: 0.4
ApplicationsWestern Blot (WB), ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis MATN3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 220-248 amino acids from the Central region of human MATN3. This gene encodes a member of von Willebrand factor Adomain containing protein family. This family of proteins isthought to be involved in the formation of filamentous networks inthe extracellular matrices of various tissues. This proteincontains two von Willebrand factor A domains; it is present in thecartilage extracellular matrix and has a role in the developmentand homeostasis of cartilage and bone. Mutations in this generesult in multiple epiphyseal dysplasia.
Immunogenn/a
Other Names[Matrilin-3; MATN3]
Gene, Accession #[MATN3], Gene ID: 4148, NCBI: NP_002372.1, UniProt: O15232
Catalog #MBS9207661
Price$165, $370
Order / More InfoMATN3 (Center), 220-248 Antibody from MYBIOSOURCE INC.
Product Specific ReferencesJoslyn, G., et al. Alcohol. Clin. Exp. Res. 34(5):800-812(2010) Zintzaras, E., et al. Am. J. Epidemiol. 171(8):851-858(2010) Otten, C., et al. Hum. Mutat. 31(3):254-263(2010) Klatt, A.R., et al. FEBS Lett. 583(22):3611-3617(2009) Vincourt, J.B., et al. Arthritis Rheum. 58(9):2798-2808(2008)
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.